001     819297
005     20220930130105.0
024 7 _ |2 doi
|a 10.1515/ract-2015-2566
024 7 _ |2 ISSN
|a 0033-8230
024 7 _ |2 ISSN
|a 2193-3405
024 7 _ |2 WOS
|a WOS:000384108400001
024 7 _ |2 Handle
|a 2128/16359
037 _ _ |a FZJ-2016-04998
041 _ _ |a English
082 _ _ |a 540
100 1 _ |0 P:(DE-Juel1)131840
|a Qaim, Syed M.
|b 0
|e Corresponding author
245 _ _ |a Uses of alpha particles, especially in nuclear reaction studies and medical radionuclide production
260 _ _ |a Berlin
|b De Gruyter
|c 2016
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1515161442_2793
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a Alpha particles exhibit three important characteristics: scattering, ionisation and activation. This article briefly discusses those properties and outlines their major applications. Among others, α-particles are used in elemental analysis, investigation and improvement of materials properties, nuclear reaction studies and medical radionuclide production. The latter two topics, dealing with activation of target materials, are treated in some detail in this paper. Measurements of excitation functions of α-particle induced reactions shed some light on their reaction mechanisms, and studies of isomeric cross sections reveal the probability of population of high-spin nuclear levels. Regarding medical radionuclides, an overview is presented of the isotopes commonly produced using α-particle beams. Consideration is also given to some routes which could be potentially useful for production of a few other radionuclides. The significance of α-particle induced reactions to produce a few high-spin isomeric states, decaying by emission of low-energy conversion or Auger electrons, which are of interest in localized internal radiotherapy, is outlined. The α-particle beam, thus broadens the scope of nuclear chemistry research related to development of non-standard positron emitters and therapeutic radionuclides.
536 _ _ |0 G:(DE-HGF)POF3-573
|a 573 - Neuroimaging (POF3-573)
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |0 P:(DE-Juel1)131849
|a Spahn, Ingo
|b 1
700 1 _ |0 P:(DE-Juel1)131846
|a Scholten, Bernhard
|b 2
700 1 _ |0 P:(DE-Juel1)166419
|a Neumaier, Bernd
|b 3
773 _ _ |0 PERI:(DE-600)2039575-9
|a 10.1515/ract-2015-2566
|g Vol. 104, no. 9
|n 9
|p 601–624
|t Radiochimica acta
|v 104
|x 2193-3405
|y 2016
856 4 _ |u https://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/819297/files/Uses%20of%20alpha%20particles%2C%20especially%20in%20nuclear%20reaction%20studies%20and%20medical%20radionuclide%20production.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:819297
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131840
|a Forschungszentrum Jülich
|b 0
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131849
|a Forschungszentrum Jülich
|b 1
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131846
|a Forschungszentrum Jülich
|b 2
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)166419
|a Forschungszentrum Jülich
|b 3
|k FZJ
913 1 _ |0 G:(DE-HGF)POF3-573
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2016
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b RADIOCHIM ACTA : 2015
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)1150
|2 StatID
|a DBCoverage
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a APC
980 1 _ |a APC
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21